Delphia Therapeutics logo

Delphia Therapeutics jobs and careers

Cambridge, United States

About Delphia Therapeutics

Delphia Therapeutics is a biotechnology company pioneering activation lethality, a new area of cancer therapeutics that target cancer's surprising vulnerability to oncogene overactivation. Delphia’s activation lethality platform offers the potential for first-in-class targeted cancer medicines that are effective on their own while also combating the emergence of drug resistance to classic targeted therapies.

Founded
2022
Employees
11 to 50
Total funding
$67M
Headquarters
Cambridge

Leadership

The top of Delphia Therapeutics's org chart, with how many people report into each leader.

KMPhoto of Kevin Marks

Kevin Marks

President & CEO

20 reports

AUPhoto of Aimee Usera

Aimee Usera

Senior Vice President Drug Discovery

15 reports

RM

Reza Mazhari

Chief Business Officer

2 reports

MD

Michael D.

Co-founder

Jobs at Delphia Therapeutics

No open positions right now. Explore more companies on TheJobsMap.